{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:53:26Z","timestamp":1764251606897,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.hlc.2019.09.012","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T14:39:49Z","timestamp":1574779189000},"page":"1039-1045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?"],"prefix":"10.1016","volume":"29","author":[{"given":"Sinan Sabit","family":"Kocabeyoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umit","family":"Kervan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-3241","authenticated-orcid":false,"given":"Dogan","family":"Emre Sert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Temizhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Aygun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Akdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Pac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hlc.2019.09.012_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","article-title":"Influence of the preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high-risk group","volume":"19","author":"Costard-Jackie","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2019.09.012_bib2","first-page":"549","article-title":"The Transplant Cardiologists Research Database Group. Pretransplantation risk factors for death after heart transplantation: a multi institutional study","volume":"12","author":"Bourge","year":"1993","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2019.09.012_bib3","first-page":"526","article-title":"Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation","volume":"9","author":"Erickson","year":"1990","journal-title":"J\u00a0Heart Transplant"},{"issue":"6","key":"10.1016\/j.hlc.2019.09.012_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ejcts.2008.12.024","article-title":"Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?","volume":"35","author":"Liden","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"issue":"9","key":"10.1016\/j.hlc.2019.09.012_bib5","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.transproceed.2007.08.069","article-title":"Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates","volume":"39","author":"Zakliczynski","year":"2007","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.hlc.2019.09.012_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1388-9842(03)00059-X","article-title":"Reversible pulmonary hypertension in heart transplant candidates-pretransplant evaluation and outcome after orthotopic heart transplantation","volume":"5","author":"Klotz","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.hlc.2019.09.012_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0012.2012.01689.x","article-title":"Bosentan in heart transplantation candidates with severe pulmonary hypertension: efficacy, safety and outcome after transplantation","volume":"27","author":"Perez-Villa","year":"2013","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.hlc.2019.09.012_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejcts.2006.12.036","article-title":"Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices","volume":"31","author":"Zimpfer","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.hlc.2019.09.012_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","article-title":"Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension","volume":"42","author":"Ghofrani","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2019.09.012_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2003.09.045","article-title":"Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation","volume":"24","author":"Butler","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2019.09.012_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4684-6015-5_15","article-title":"Ca\/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues","volume":"308","author":"Ahn","year":"1991","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.hlc.2019.09.012_bib12","first-page":"291","article-title":"Oral sildenafil: Potential role in heart transplantation. Review of the literature and personal experience","volume":"55","author":"Sansone","year":"2010","journal-title":"J\u00a0Cardiol"},{"issue":"7","key":"10.1016\/j.hlc.2019.09.012_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","article-title":"Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension","volume":"136","author":"Ghofrani","year":"2002","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.hlc.2019.09.012_bib14","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.transproceed.2013.03.040","article-title":"Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation","volume":"45","author":"Lopez-Meseguer","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hlc.2019.09.012_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12890-015-0164-2","article-title":"Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study","volume":"16","author":"Gall","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"7","key":"10.1016\/j.hlc.2019.09.012_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004843","article-title":"Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review","volume":"4","author":"Dzudie","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.hlc.2019.09.012_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/2045-8932.97598","article-title":"Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction","volume":"2","author":"Perez","year":"2012","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2019.09.012_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A\u00a0randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2019.09.012_bib19","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.jacc.2004.09.041","article-title":"The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary haemodynamics and diffusion capacity, exercise ventilator efficiency, and oxygen uptake kinetics in chronic heart failure","volume":"44","author":"Guazzi","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2019.09.012_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: A target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hlc.2019.09.012_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCHEARTFAILURE.112.969071","article-title":"Heart Failure Clinical Research Network. Phosphodiesterase-5 inhibition in diastolic heart failure: the RELAX trial rationale and design","volume":"5","author":"Redfield","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.hlc.2019.09.012_bib22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/hc3601.096826","article-title":"Effect of inhaled iloprost plus oral sidenafil in patients with primary pulmonary hypertension","volume":"104","author":"Wilkens","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hlc.2019.09.012_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1086\/681264","article-title":"Use of pulmonary arterial hypertension\u2013approved therapy in the treatment of non\u2013group 1 pulmonary hypertension at US referral centers","volume":"5","author":"Trammell","year":"2015","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2019.09.012_bib24","first-page":"173","article-title":"Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation","volume":"12","author":"Iberer","year":"1993","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2019.09.012_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-5223(97)70053-9","article-title":"Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality","volume":"114","author":"Chen","year":"1997","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.hlc.2019.09.012_bib26","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.athoracsur.2006.05.114","article-title":"Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant","volume":"82","author":"Klotz","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.hlc.2019.09.012_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jtcvs.2006.08.104","article-title":"Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates","volume":"133","author":"Zimpfer","year":"2007","journal-title":"J\u00a0Thorac Cardiovasc Surg"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950619314817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950619314817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T20:43:59Z","timestamp":1731098639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950619314817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1443950619314817"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2019.09.012","relation":{},"ISSN":["1443-9506"],"issn-type":[{"type":"print","value":"1443-9506"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2019.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}